Jefferies Group Research Analysts Lower Earnings Estimates for Analogic Co. (ALOG)
Analogic Co. (NASDAQ:ALOG) – Investment analysts at Jefferies Group dropped their Q3 2018 earnings per share (EPS) estimates for shares of Analogic in a report issued on Wednesday. Jefferies Group analyst A. Petrone now expects that the medical research company will post earnings of $0.76 per share for the quarter, down from their prior forecast of $1.00. Jefferies Group currently has a “Hold” rating and a $80.00 target price on the stock.
Analogic (NASDAQ:ALOG) last announced its quarterly earnings data on Wednesday, December 6th. The medical research company reported $0.75 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.32. Analogic had a positive return on equity of 5.09% and a negative net margin of 15.06%. The business had revenue of $106.90 million during the quarter, compared to analyst estimates of $100.55 million. During the same period in the prior year, the company earned $0.43 earnings per share. Analogic’s revenue was down 11.7% compared to the same quarter last year.
Analogic (ALOG) opened at $86.00 on Monday. Analogic has a twelve month low of $66.00 and a twelve month high of $88.45. The company has a market capitalization of $1,073.69, a price-to-earnings ratio of 44.10, a PEG ratio of 4.30 and a beta of 0.86.
The business also recently declared a quarterly dividend, which will be paid on Friday, December 29th. Stockholders of record on Friday, December 15th will be issued a $0.10 dividend. This represents a $0.40 dividend on an annualized basis and a dividend yield of 0.47%. The ex-dividend date of this dividend is Thursday, December 14th. Analogic’s payout ratio is currently -6.99%.
Institutional investors have recently bought and sold shares of the company. Flinton Capital Management LLC boosted its holdings in shares of Analogic by 100.0% in the second quarter. Flinton Capital Management LLC now owns 1,768 shares of the medical research company’s stock worth $129,000 after acquiring an additional 884 shares during the period. State Board of Administration of Florida Retirement System purchased a new stake in shares of Analogic in the third quarter worth $224,000. Piedmont Investment Advisors LLC purchased a new stake in shares of Analogic in the third quarter worth $227,000. Crossmark Global Holdings Inc. purchased a new stake in shares of Analogic in the third quarter worth $250,000. Finally, Oppenheimer & Co. Inc. purchased a new stake in shares of Analogic in the second quarter worth $263,000. 97.82% of the stock is owned by hedge funds and other institutional investors.
Analogic Company Profile
Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.
Receive News & Ratings for Analogic Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic Co. and related companies with MarketBeat.com's FREE daily email newsletter.